Replies to post #311357 on Amarin Corp Plc (AMRN)

[Number sleven]

AI, Amarin had their marine Patents invalidated. R-IT patents are still solid. Hikma can not sell to the R-IT market without infringing.
Sleven,

[postes]

The scary thing would be if MTNB trial showed a superior drug for >500 and then starting looking at cv disease potential.
The water may never be safe..
Concede US stockpile cash sell company.